GlassScriptPhysician profile
Kevin G Mcaree
NPI 1114011350
$942.10
in general payments reported to CMS, 2019-2025
22 companies · $22.68 in 2025
The $22.68 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $260 · 2022: $85.51 · 2023: $64.34 · 2024: $147 · 2025: $22.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $137.32 | 2019-2020 | |
| Smith+Nephew, INC. | $135.93 | 2019-2024 | Collagenase Santyl, Pico, Renasys Touch |
| Tela Bio, INC. | $102.08 | 2019-2020 | |
| Intuitive Surgical, INC. | $71.84 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $70.78 | 2022-2023 | Exparel |
| Integra Lifesciences Corporation | $40.24 | 2020 | |
| Solventum Corporation | $36.14 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Medtronic, INC. | $33.77 | 2024 | Progrip |
| Tei Biosciences INC | $33.40 | 2019 | |
| Covidien LP | $32.78 | 2019-2020 | |
| Davol INC. | $31.66 | 2020 | |
| Acell, INC. | $25.23 | 2019 | |
| Eagle Pharmaceuticals, INC. | $25.07 | 2023 | |
| Polynovo North America LLC | $23.33 | 2019 | |
| Djo, LLC | $22.68 | 2025 | Cmf |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $21.41 | 2022 | |
| Angiodynamics, INC. | $20.24 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $18.75 | 2019 | |
| Ethicon US, LLC | $16.31 | 2023 | Echelon Flex |
| Merck Sharp & Dohme LLC | $16.28 | 2022 | |
| Allergan, INC. | $13.63 | 2019 | |
| Organogenesis INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcaree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.